Article

Entrectinib - a SARS-CoV-2 inhibitor in Human Lung Tissue (HLT) cells

2021-09-07

Abstract excerpt

Since the start of the COVID-19 outbreak, pharmaceutical companies and research groups have focused on the development of vaccines and antiviral drugs against SARS-CoV-2. Here, we apply a drug repurposing strategy to identify potential drug candidates that are able to block the entrance of the virus into human cells. By combining virtual screening with in vitro pseudovirus assays and antiviral assays in Human Lung...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a39600ed-4e54-59c7-b44b-81011dacc8e5
DOI: 10.1101/2021.09.07.459123

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Entrectinib - a SARS-CoV-2 inhibitor in Human Lung Tissue (HLT) cellsDOI 10.1101/2021.09.07.459123Read

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung OrganoidsSemantic proximity Read

Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targetsSemantic proximity Read

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2Semantic proximity Read

Genome-wide Screening Identifies Unique Host-Directed Drugs and Pro-viral Signalling Pathways for SARS-CoV-2Semantic proximity Read

A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanismSemantic proximity Read

Genome-wide Screening Identifies Unique Host-Directed Drugs and Pro-viral Signalling Pathways for SARS-CoV-2Semantic proximity Read

Human cell receptors: potential drug targets to combat COVID-19Semantic proximity Read

The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in CancerSemantic proximity Read

Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in miceSemantic proximity Read

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSemantic proximity Read

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactomeSemantic proximity Read

Discovering small-molecule therapeutics against SARS-CoV-2Semantic proximity Read